Skip to main content

Lecture Notes on Anticoagulants (Heparin & Warfarin)

Overview of the Topics
Anticoagulant Drugs

Anticoagulant drugs: 

- Drugs that inhibit the development and enlargement of clots by action on the coagulation phase. 
- Do not lyse clots or affect the fibrinolytic pathways 


Clinical Indication for Anticoagulant therapy
- Deep Vein Thrombosis
- Arterial Embolism
- Arterial Fibrillation 
- Unstable angina and myocardial infarction

Heparin (Intravenous or subcutaneous administration)

- Heparin is a sulfated acidic mucopolysaccharide that is widely distributed in the body
- Two types of heparin are used clinically
- Standard Unfractionated Heparin
- Low Molecular Weight Heparin

Standard Unfractionated Heparin

- Heparin (heparin sodium) is a mixture of highly electronegative acidic mucopolysaccharides that contain numerous N- and O-sulfate linkages. 
- The unfractionated preparation is extracted from the lung or intestine of ox, pig, and is a mixture of polymers of variable molecular weight.
- Unfractionated heparin is rarely used and is now replaced by lower molecular weight heparin 
- But it is still administered to patients with impaired or rapidly changing renal function,
- For prophylaxis, a low dose is injected subcutaneously into the fatty layer of the lower abdomen 8- or 12 hourly. 

Lower Molecular Weight Heparin (LMWH)

- Lower molecular weight heparin is produced by chemical depolymerization and extraction of standard heparin
- Molecular weight ranges from 2000 to 9000 
- The LMWH has 2-4 fold greater anti-factor Xa activity than antithrombin activity
- LMWH has greater bioavailability than standard heparin and dose-dependent clearance pharmacokinetics

Mechanism of action
- Heparin binds to the serine protease inhibitor, antithrombin III
- It induces a conformational change that accelerates the interaction of antithrombin to coagulation factors (IIa, IXa, Xa, XIa, and XIIa) resulting in rapid inactivation 
- Heparin also catalyzes the inhibition thrombin by heparin cofactor II
- Monitoring of the treatment effect is done by measurement of Partial thromboplastin time (PTT)

Absorption, Metabolism, and Excretion
- Heparin is not absorbed from the gastrointestinal tract, therefore, must be given parenterally
- Intravenous administration results in an almost rapid immediate anticoagulant effect 
- Half-life of unfractionated heparin range from 0.5-2.5 hour, and is dose-dependent
- Unfractionated heparin is rapidly taken up by the reticuloendothelial system for degradation and renal excretion
- The LMWH are solely cleared through urine, therefore, the unfractionated heparin is recommended to an individual with renal dysfunction
- Both forms of heparin do not cross the placental barrier, therefore, the anticoagulant of choice during pregnancy 

Indication (Rapid Anticoagulation -intensive)
- Deep Vein Thrombosis
- Arterial Embolism
- Arterial Fibrillation 
- Unstable angina and myocardial infarction

Other Pharmacological Effects
- Exerts antilipemic effects by releasing lipoprotein lipase from endothelial cells
- Decreases platelet aggregation and inflammatory cell adhesiveness to endothelial cells.
- Reduces platelet like growth factors and exert an antiproliferative effect on smooth muscle 

Toxicity
Bleeding, -
- Osteoporosis, -
- Heparin-induced thrombocytopenia, 
- Hypersensitivity

Warfarin (Oral Administration)

- Warfarin is a fat-soluble derivative of 4-hydroxycoumarin and they serve as Vitamin K antagonists
- Decreases blood coagulation by inhibiting the synthesis of coagulation factors

Mechanisms of Action:
- Warfarin inhibits the hepatic synthesis of vitamin K dependent coagulation factors II, VII, IX & X 
- Vitamin K dependent carboxylation of glutamic acid residue at the N terminal end these coagulation factors precursors are blocked by warfarin
- Warfarin specifically targets epoxide reductase, thereby inhibiting the recycling of active hydroxyquinone that is required for carboxylation. 

Absorption, Metabolism, and Excretion
- Complete reabsorption after oral administration of warfarin
- Maximal plasma concentration is reached within 2-8 hours, and approximately 95% of the drugs are bound to plasma proteins
- Warfarin is metabolized and inactivated by the hepatic microsomal P450 enzyme
- Hydroxylated metabolites are excreted into bile and into the intestine
- Monitoring of the treatment effect is done by measurement of Prothrombin time (PT)

Indications  (Longer-term regimen)
-Deep vein Thrombosis 
-Pulmonary Embolism
-Arterial Fibrillation
-Mitral Stenosis
-Prosthetic valve replacement 

Toxicity 
- Hemorrhage and bleeding
- Warfarin does not cross the blood-brain barrier but it crosses the placental barrier 
- Causes teratogenesis to the fetus
- Causes hypercoagulability in individuals with impaired hepatic function
- Interaction with drugs that binds to plasma proteins and are metabolized by P450 enzymes 
    - Inducers: Barbiturates, Carbamazepine, Rifampin
    - Inhibitors: Cimetidine, Macrolides, Azole

Comments

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

MCQs and Answers on cultivation (culture/incubation), Isolation and Identification of microorganisms: Medical Microbiology

40 plus questions - Multiple Choice Questions on Classification, Culture, and Identification of the microorganisms 1. Which of the following microorganism has the cocci cell shapes and sizes arranged usually in tetrad structures? a)  Streptococcus pneumoniae b)  Staphylococcus aureus c)  Chlamydia trachomatis d)  Neisseria meningitidis 2. What are the different growth morphology and cell structures used for the classification of fungi? Select all the correct answers: a) Yeast b) Mold c) Mycelia d) Protozoa 3. Which of the following media is formulated with additional nutrients to support the growth of fastidious or nutritionally demanding bacteria that may not grow well on basic media? a) Differential media b) Enriched media c) Nutrient agar (media) d) Selective media 4. Which of the following metabolic characteristic is a distinguishing characteristic and identification of colonies of  E. coli ? a) Hydrogen sulfide formation b) Indole Formation c) Lactose fe...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...